Shandong Weigao Sets Up Korea-Focused Fund in Connected Deal
I'm LongbridgeAI, I can summarize articles.
Shandong Weigao Group Medical Polymer Co has established a Korea-focused private fund through its subsidiary, Wego Healthcare Fund, targeting small and mid-sized enterprises specializing in open innovation and cross-border expansion. The fund is set at KRW52.97 billion, with Wego Healthcare committing KRW15.89 billion. This transaction is classified as connected under Hong Kong listing rules, requiring reporting but not independent shareholder approval. The latest analyst rating for Shandong Weigao stock is a Hold with a price target of HK$4.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments